In what types of solid tumors has mutation-directed therapy been shown to improve patient outcomes, including progression-free survival (PFS) and overall (OS)?

In what types of solid tumors has mutation-directed therapy been shown to improve patient outcomes, including progression-free survival (PFS) and overall (OS)?

In what types of solid tumors has mutation-directed therapy been shown to improve patient outcomes, including progression-free survival (PFS) and overall (OS)?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Jinming Yu, MD, PhD

Professor Jinming Yu, MD, PhD

President, Shandong Cancer Hospital and Institute
Jinan, Shandong
China